These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 25618015

  • 1. Synthesis, anticancer and radiosensitizing evaluation of some novel sulfonamide derivatives.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, Zahran SS.
    Eur J Med Chem; 2015 Mar 06; 92():682-92. PubMed ID: 25618015
    [Abstract] [Full Text] [Related]

  • 2. Design and synthesis of some novel 4-Chloro-N-(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents.
    Ghorab MM, Ragab FA, Heiba HI, Soliman AM.
    Eur J Med Chem; 2016 Jul 19; 117():8-18. PubMed ID: 27085944
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
    Ghorab MM, Ragab FA, Heiba HI, Youssef HA, El-Gazzar MG.
    Bioorg Med Chem Lett; 2010 Nov 01; 20(21):6316-20. PubMed ID: 20850308
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, in-vitro anticancer screening and radiosensitizing evaluation of some new N-(quinoxalin-2-yl)benzenesulfonamide derivatives.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MG.
    Arzneimittelforschung; 2012 Jan 01; 62(1):46-52. PubMed ID: 22331763
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS, Ghorab MM, Alsaid MS, Nissan YM, Ahmed AB.
    Eur J Med Chem; 2013 Nov 01; 69():373-83. PubMed ID: 24077528
    [Abstract] [Full Text] [Related]

  • 6. Study of reactivity of cyanoacetohydrazonoethyl-N-ethyl-N-methyl benzenesulfonamide: preparation of novel anticancer and antimicrobial active heterocyclic benzenesulfonamide derivatives and their molecular docking against dihydrofolate reductase.
    Debbabi KF, Al-Harbi SA, Al-Saidi HM, Aljuhani EH, Abd El-Gilil SM, Bashandy MS.
    J Enzyme Inhib Med Chem; 2016 Nov 01; 31(sup4):7-19. PubMed ID: 27557134
    [Abstract] [Full Text] [Related]

  • 7. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MGM.
    Bioorg Med Chem Lett; 2018 May 15; 28(9):1464-1470. PubMed ID: 29628325
    [Abstract] [Full Text] [Related]

  • 8. In vitro anticancer screening and radiosensitizing evaluation of some new quinolines and pyrimido[4,5-b]quinolines bearing a sulfonamide moiety.
    Ghorab MM, Ragab FA, Heiba HI, Arafa RK, El-Hossary EM.
    Eur J Med Chem; 2010 Sep 15; 45(9):3677-84. PubMed ID: 20684857
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of some new pyrazole and pyrimidine derivatives carrying a sulfonamide moiety of expected antitumor activity and study of the synergistic effect of gamma-irradiation.
    Ghorab MM, Ragab FA, Heiba HI, Youssef HA, Galal M.
    Arzneimittelforschung; 2010 Sep 15; 60(1):48-55. PubMed ID: 20184227
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives.
    El-Said MS, El-Gazzar MG, Al-Dosari MS, Ghorab MM.
    Arzneimittelforschung; 2012 Mar 15; 62(3):149-56. PubMed ID: 22270843
    [Abstract] [Full Text] [Related]

  • 11. Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety.
    Ghorab MM, Shaaban MA, Refaat HM, Heiba HI, Ibrahim SS.
    Eur J Med Chem; 2012 Jul 15; 53():403-7. PubMed ID: 22583778
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and in vitro anticancer screening of some novel 4-[2-amino-3-cyano-4-substituted-5,6,7,8-tetrahydroquinolin-1-(4H)-yl]benzenesulfonamides.
    Al-Said MS, Ghorab MM, Al-Qasoumi SI, El-Hossary EM, Noaman E.
    Eur J Med Chem; 2010 Jul 15; 45(7):3011-8. PubMed ID: 20413187
    [Abstract] [Full Text] [Related]

  • 13. Anticancer and radio-sensitizing evaluation of some new thiazolopyrane and thiazolopyranopyrimidine derivatives bearing a sulfonamide moiety.
    Ghorab MM, Ragab FA, Heiba HI, El-Hazek RM.
    Eur J Med Chem; 2011 Oct 15; 46(10):5120-6. PubMed ID: 21890248
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, in vitro anticancer screening and radiosensitizing evaluation of some new 4-[3-(substituted)thioureido]-N-(quinoxalin-2-yl)-benzenesulfonamide derivatives.
    Ghorab MM, Ragab FA, Heiba HI, El-Gazzar MG, El-Gazzar MG.
    Acta Pharm; 2011 Dec 15; 61(4):415-25. PubMed ID: 22202200
    [Abstract] [Full Text] [Related]

  • 15. Utility of methyl 2-isothiocyanatobenzoate in the synthesis of some new quinazoline derivatives as potential anticancer and radiosensitizing agents.
    Ghorab MM, Ragab FA, Heiba HI, Bayomi AA.
    Arzneimittelforschung; 2011 Dec 15; 61(12):719-26. PubMed ID: 22282960
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
    Halawa AH, Elgammal WE, Hassan SM, Hassan AH, Nassar HS, Ebrahim HY, Mehany ABM, El-Agrody AM.
    Bioorg Chem; 2020 May 15; 98():103725. PubMed ID: 32199303
    [Abstract] [Full Text] [Related]

  • 17. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
    Ghorab MM, Alsaid MS, Nissan YM, Ashour AE, Al-Mishari AA, Kumar A, Ahmed SF.
    Chem Pharm Bull (Tokyo); 2016 May 15; 64(12):1747-1754. PubMed ID: 27904083
    [Abstract] [Full Text] [Related]

  • 18. Novel pyrazole derivatives as anticancer and radiosensitizing agents.
    Aly HM, El-Gazzar MG.
    Arzneimittelforschung; 2012 Mar 15; 62(3):105-12. PubMed ID: 22407898
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and pro-apoptotic effects of new sulfonamide derivatives via activating p38/ERK phosphorylation in cancer cells.
    Cumaoglu A, Dayan S, Agkaya AO, Ozkul Z, Ozpozan NK.
    J Enzyme Inhib Med Chem; 2015 Jun 15; 30(3):413-9. PubMed ID: 25198886
    [Abstract] [Full Text] [Related]

  • 20. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
    Pingaew R, Prachayasittikul V, Worachartcheewan A, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V.
    Eur J Med Chem; 2015 Oct 20; 103():446-59. PubMed ID: 26397393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.